Willis Towers Watson WTW · NASDAQ
$315.49 +1.65% (+$5.13)
Summary
64 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 22% a year over the last 3 years.
- It has raised its dividend 14 years in a row and pays out only 23% of profit.
- It bought back its own shares for $1.65B in the last fiscal year, 5.7% of its market value.
What to watch
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 18.4 USD for 1 USD of yearly profit. Over the last five years it was 19.7 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 2.4% a year over 5 years. Over the last 3 years it grew by 3.1% a year. For the next fiscal year analysts expect revenue to grow by 7.7%. Earnings per share grew by 22% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 46 USD
- Sales and administration 32 USD
- Taxes and other 6.7 USD
- Net profit 15 USD
Net profit, industry median (Insurance - Brokers) 10 USD
Out of every 100 USD of revenue, 15 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.22%
- Paid out of profit
- 23%
- Raised in a row
- 14 years
You receive $3.80 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 18
- Hold 10
- Sell 1
Today's price within the analysts' price targets
The average target of $354.27 is 12% above today's price. 62% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Health, Wealth and Career 55%
- Risk and Broking 45%
By region
- International 50%
- UNITED STATES 23%
- Rest Of World 16%
- UNITED KINGDOM 11%
- IRELAND 0.7%
Health, Wealth and Career brings in 55% of revenue. Risk and Broking grew fastest, by 7.8% a year.
Segments in detail